The Retain Your Brain Health Study (RetainYourBrain.com)

NCT ID: NCT06027320

Last Updated: 2024-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

992 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-07

Study Completion Date

2024-09-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test a cell phone-based online program that provides Alzheimer's risk assessments and memory tests over a 6-month period. The main question it aims to answer is whether online software can help reduce the risk of Alzheimer's disease (AD) through digital education and tracking.

Participants will visit RetainYourBrain.com to answer questions about their risk factors for AD and take online word recall and card game cognitive tests. Researchers will track progress over time and compare different strategies of Alzheimer's education to see if it is possible to protect brain health, reduce Alzheimer's risk, and improve memory function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Alzheimer's disease (AD) is a public health crisis with few effective treatments. Most people are unaware that AD begins in the brain decades before the first symptoms of memory loss begin. That leaves a lot of time for people to learn their individual risk factors for AD and cognitive decline and take memory assessment screening tests in an effort toward the prevention or delay of dementia. To reach a growing at-risk population, mobile health technologies accessible via cell phone can fill an unmet need due to their accessibility and cost-effective delivery of care. Online education and text messaging have proven to be effective methods of reducing risk for a variety of chronic conditions, including cardiovascular disease and diabetes, which are both key drivers of AD risk.

The investigators created a cell phone-based online software application to provide automated, individualized monitoring and education at broad scale. The goal of the software is to function as a digital therapeutic to identify individual risk factors, assess memory and cognitive function over time, and provide education to people with a family history of AD. The system maintains bi-directional communication via text message to verify participant engagement.

Potential participants who visit our study website (www.RetainYourBrain.com) will be directed to answer questions assessing eligibility criteria. Participants who are eligible are asked to electronically sign an informed consent form, complete baseline assessments, and take online word recall and card game cognitive tests. Participants will then be randomized to one of two groups using different strategies for AD risk assessment education. Researchers will track progress over six months and compare different strategies of education to determine if it is possible to protect brain health, reduce Alzheimer's risk, and improve memory function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease Dementia Healthy Participants Brain Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brain Health Education Arm

Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.

Group Type EXPERIMENTAL

Brain Health Education

Intervention Type BEHAVIORAL

Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.

Alzheimer Disease Education Arm

Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.

Group Type OTHER

Alzheimer Disease Education

Intervention Type BEHAVIORAL

Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brain Health Education

Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.

Intervention Type BEHAVIORAL

Alzheimer Disease Education

Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be at least 53 years of age
* have a family history of Alzheimer's Disease (AD)
* have a compatible phone/device (phone allowing text messages and with internet access, and/or tablet device with the same capabilities)
* a minimum of one of the following risk factors: body mass index (BMI) of \< 25 kg/m2, history of pre-diabetes/diabetes, high blood pressure, high cholesterol, smoking, low physical activity, low fish intake (\< 3 times per month), high alcohol intake (\< 7 servings per week for a women and \<14 servings a week for men), diagnosed with mild or moderate depression.

Exclusion Criteria

* have a diagnosis of dementia due to AD
* other dementia
* women who are currently pregnant or who plan on becoming pregnant in the next 6 months
* BMI \<18.5 kg/m2
* consuming \>35 alcoholic drinks/week for men or \>28 alcoholic drinks/week for women
* severe depression (PHQ-9 score of more than 15)
* current treatment for cancer
* diagnosis of Parkinson's disease, amyotrophic lateral sclerosis, Lewy body dementia, frontotemporal disorders, multiple sclerosis, or other neurodegenerative disease
* current treatment for an eating disorder
* currently prescribed insulin for type I or II diabetes
* inability to give informed consent or complete identity verification
* participating in another AD trial.
Minimum Eligible Age

53 Years

Maximum Eligible Age

105 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

Retain Health, Inc

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tammie Elgammal, MD

Role: PRINCIPAL_INVESTIGATOR

Retain Health, Inc

Robert Krikorian, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Cincinnati School of Medicine

Mark McInnis, BA

Role: PRINCIPAL_INVESTIGATOR

Retain Health, Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Retain Health, Inc.

Bedford, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4R44AG071416

Identifier Type: NIH

Identifier Source: secondary_id

View Link

20216157

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resilience and Brain Health of Older Adults (MEDEX-2)
NCT05124132 ENROLLING_BY_INVITATION NA
The Cognitive Resilience Study
NCT03016702 COMPLETED NA
The Brain Health Champion Study
NCT03772977 ACTIVE_NOT_RECRUITING NA
Brain Balance Study
NCT05714150 RECRUITING NA